It’s noteworthy that pretreatment with PAH did not affect the basal levels of serum IFN-β and the basal ISG mRNA levels of the hearts and spleens (Figures S3A–C), revealing that PAH did not change the in vivo immune circumstance. The gene discussed is IFNB1; the disease is pulmonary arterial hypertension.